197 related articles for article (PubMed ID: 35283318)
1. Mendelian susceptibility to mycobacterial diseases: state of the art.
Noma K; Mizoguchi Y; Tsumura M; Okada S
Clin Microbiol Infect; 2022 Nov; 28(11):1429-1434. PubMed ID: 35283318
[TBL] [Abstract][Full Text] [Related]
2. Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ.
Tsumura M; Miki M; Mizoguchi Y; Hirata O; Nishimura S; Tamaura M; Kagawa R; Hayakawa S; Kobayashi M; Okada S
J Allergy Clin Immunol; 2022 Jan; 149(1):252-261.e6. PubMed ID: 34176646
[TBL] [Abstract][Full Text] [Related]
3. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients.
Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA
J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053
[TBL] [Abstract][Full Text] [Related]
4. Mendelian susceptibility to mycobacterial disease: 2014-2018 update.
Rosain J; Kong XF; Martinez-Barricarte R; Oleaga-Quintas C; Ramirez-Alejo N; Markle J; Okada S; Boisson-Dupuis S; Casanova JL; Bustamante J
Immunol Cell Biol; 2019 Apr; 97(4):360-367. PubMed ID: 30264912
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.
Kong XF; Vogt G; Itan Y; Macura-Biegun A; Szaflarska A; Kowalczyk D; Chapgier A; Abhyankar A; Furthner D; Djambas Khayat C; Okada S; Bryant VL; Bogunovic D; Kreins A; Moncada-Vélez M; Migaud M; Al-Ajaji S; Al-Muhsen S; Holland SM; Abel L; Picard C; Chaussabel D; Bustamante J; Casanova JL; Boisson-Dupuis S
Hum Mol Genet; 2013 Feb; 22(4):769-81. PubMed ID: 23161749
[TBL] [Abstract][Full Text] [Related]
6. Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway.
Haake K; Neehus AL; Buchegger T; Kühnel MP; Blank P; Philipp F; Oleaga-Quintas C; Schulz A; Grimley M; Goethe R; Jonigk D; Kalinke U; Boisson-Dupuis S; Casanova JL; Bustamante J; Lachmann N
Cells; 2020 Feb; 9(2):. PubMed ID: 32093117
[TBL] [Abstract][Full Text] [Related]
7. Mendelian susceptibility to mycobacterial disease: recent discoveries.
Bustamante J
Hum Genet; 2020 Jun; 139(6-7):993-1000. PubMed ID: 32025907
[TBL] [Abstract][Full Text] [Related]
8. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J
Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462
[TBL] [Abstract][Full Text] [Related]
9. A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease.
Ye F; Zhang W; Dong J; Peng M; Fan C; Deng W; Zhang H; Yang L
Front Cell Infect Microbiol; 2022; 12():1002140. PubMed ID: 36339330
[TBL] [Abstract][Full Text] [Related]
10. Inherited human IFN-γ deficiency underlies mycobacterial disease.
Kerner G; Rosain J; Guérin A; Al-Khabaz A; Oleaga-Quintas C; Rapaport F; Massaad MJ; Ding JY; Khan T; Ali FA; Rahman M; Deswarte C; Martinez-Barricarte R; Geha RS; Jeanne-Julien V; Garcia D; Chi CY; Yang R; Roynard M; Fleckenstein B; Rozenberg F; Boisson-Dupuis S; Ku CL; Seeleuthner Y; Béziat V; Marr N; Abel L; Al-Herz W; Casanova JL; Bustamante J
J Clin Invest; 2020 Jun; 130(6):3158-3171. PubMed ID: 32163377
[TBL] [Abstract][Full Text] [Related]
11. Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases.
Lee WI; Huang JL; Wu TS; Lee MH; Chen IJ; Yu KH; Liu CY; Yang CH; Hsieh MY; Lin YL; Shih YF; Jaing TH; Huang SC; Kuo TT; Ku CL
Immunobiology; 2013 May; 218(5):762-71. PubMed ID: 23083630
[TBL] [Abstract][Full Text] [Related]
12. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases.
Al-Muhsen S; Casanova JL
J Allergy Clin Immunol; 2008 Dec; 122(6):1043-51; quiz 1052-3. PubMed ID: 19084105
[TBL] [Abstract][Full Text] [Related]
13. Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases.
Ono R; Tsumura M; Shima S; Matsuda Y; Gotoh K; Miyata Y; Yoto Y; Tomomasa D; Utsumi T; Ohnishi H; Kato Z; Ishiwada N; Ishikawa A; Wada T; Uhara H; Nishikomori R; Hasegawa D; Okada S; Kanegane H
J Clin Immunol; 2023 Feb; 43(2):466-478. PubMed ID: 36336768
[TBL] [Abstract][Full Text] [Related]
14. Disseminated Mycobacterium avium complex infection in a child with partial dominant interferon gamma receptor 1 deficiency in India.
Sharma VK; Pai G; Deswarte C; Lodha R; Singh S; Kang LW; Yin CC; Casanova JL; Bustamante J; Kabra SK
J Clin Immunol; 2015 Jul; 35(5):459-62. PubMed ID: 26054576
[TBL] [Abstract][Full Text] [Related]
15. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.
Bustamante J; Boisson-Dupuis S; Abel L; Casanova JL
Semin Immunol; 2014 Dec; 26(6):454-70. PubMed ID: 25453225
[TBL] [Abstract][Full Text] [Related]
16. A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.
Oleaga-Quintas C; Deswarte C; Moncada-Vélez M; Metin A; Krishna Rao I; Kanık-Yüksek S; Nieto-Patlán A; Guérin A; Gülhan B; Murthy S; Özkaya-Parlakay A; Abel L; Martínez-Barricarte R; Pérez de Diego R; Boisson-Dupuis S; Kong XF; Casanova JL; Bustamante J
Hum Mol Genet; 2018 Nov; 27(22):3919-3935. PubMed ID: 31222290
[TBL] [Abstract][Full Text] [Related]
17. Mendelian susceptibility to mycobacterial diseases: State of the puzzle.
Errami A; Bousfiha AA
Qatar Med J; 2023; 2023(2):25. PubMed ID: 38025345
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.
van Coller A; Glanzmann B; Cornelissen H; Möller M; Kinnear C; Esser M; Glashoff R
BMC Immunol; 2021 Sep; 22(1):62. PubMed ID: 34517836
[TBL] [Abstract][Full Text] [Related]
19. A heterozygous dominant-negative mutation in the coiled-coil domain of STAT1 is the cause of autosomal-dominant Mendelian susceptibility to mycobacterial diseases.
Ueki M; Yamada M; Ito K; Tozawa Y; Morino S; Horikoshi Y; Takada H; Abdrabou SS; Takezaki S; Kobayashi I; Ariga T
Clin Immunol; 2017 Jan; 174():24-31. PubMed ID: 27856304
[TBL] [Abstract][Full Text] [Related]
20. Two novel STAT1 mutations cause Mendelian susceptibility to mycobacterial disease.
Liu Z; Zhou M; Yuan C; Ni Z; Liu W; Tan Y; Zhang D; Zhou X; Zou T; Wang J; Hou M; Peng X; Zhang X
Biochem Biophys Res Commun; 2022 Feb; 591():124-129. PubMed ID: 34815077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
